Tandem Diabetes Care (TNDM) Return on Capital Employed Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,127.00 |
| Dec 31, 2025 | -2,814.00 |
| Sep 30, 2025 | -2,696.00 |
| Jun 30, 2025 | -2,274.00 |
| Mar 31, 2025 | -1,894.00 |
| Dec 31, 2024 | -589.00 |
| Sep 30, 2024 | -886.00 |
| Jun 30, 2024 | -131.00 |
| Mar 31, 2024 | 1,049.00 |
| Dec 31, 2023 | 391.00 |
| Sep 30, 2023 | 2,068.00 |
| Jun 30, 2023 | 1,810.00 |
| Mar 31, 2023 | 5,029.00 |
| Dec 31, 2022 | 10,276.00 |
| Sep 30, 2022 | 9,730.00 |
| Jun 30, 2022 | 10,878.00 |
| Mar 31, 2022 | 9,732.00 |
| Dec 31, 2021 | 11,472.00 |
| Sep 30, 2021 | 12,098.00 |
| Jun 30, 2021 | 7,835.00 |
| Mar 31, 2021 | 6,969.00 |
| Dec 31, 2020 | 6,759.00 |
| Sep 30, 2020 | 6,232.00 |
| Jun 30, 2020 | 5,020.00 |
| Mar 31, 2020 | 5,895.00 |
| Dec 31, 2019 | 7,303.00 |
| Sep 30, 2019 | 5,879.00 |
| Jun 30, 2019 | 3,649.00 |
| Mar 31, 2019 | 1,535.00 |